Despite this unfavorablescenario, we are currently exploring whether chloroquine-induced inhibition of the final step in theautophagic pathway sensitizes autophagy-addicted [109],trastuzumab-refractory HER2-positive breast cancer cells to the growth inhibitory activity oftrastuzumab. This evidence concerns the gene ERBB2 and breast carcinoma.